This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hokko Chemical Industry Co., Ltd.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: The Innovations of Takeshi Kawarabayashi
Introduction
Takeshi Kawarabayashi is a notable inventor based in Hirosaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative vaccine technologies. With a total of 2 patents, his work focuses on addressing critical health issues, including Alzheimer's disease.
Latest Patents
Kawarabayashi's latest patents include a transformed soybean plant that accumulates a vaccine. This invention involves a soybean plant engineered to contain a gene encoding a modified seed storage protein. The gene is introduced by inserting a gene encoding an Alzheimer's disease vaccine into a variable region of a wild-type seed storage protein. This innovative approach allows for the production and accumulation of the vaccine in the seeds of the soybean plant. Another significant patent is a vaccine composition for the prophylaxis and therapy of Alzheimer's disease. This composition comprises a fusion protein created by inserting multiple copies of an amyloid β antigenic peptide into a wild-type seed storage protein, targeting the prevention and treatment of this debilitating condition.
Career Highlights
Kawarabayashi is associated with Hokko Chemical Industry Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health and agricultural biotechnology.
Collaborations
Some of his notable coworkers include Teruhiko Terakawa and Mikio Shoji, who contribute to the collaborative efforts in their research projects.
Conclusion
Takeshi Kawarabayashi's innovative work in biotechnology, particularly in vaccine development, showcases his commitment to addressing significant health challenges. His contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile